Newly funded research from Milan Vrabel and his team at @iocbprague aims to transform the production of cancer-killing cells, making their use (via immunotherapy) more effective and affordable.

Find out more on 👉 https://erc.europa.eu/news-events/news/proof-concept-2022-highlighted-projects#CHEMCELL

#EUCancerPlan #EU2023SE #CloseTheCareGap

🐦🔗: https://n.respublicae.eu/ERC_Research/status/1621825928430239745